Key result
Vitamin D <20 ng/ml is linked to ~24-fold higher odds of abnormal VLF in advanced DKD.
Why the study?
Cardiovascular autonomic neuropathy may be linked to diabetes complications, and lower vitamin D levels have been associated with diabetic kidney disease and neuropathy, but their relationship across kidney disease stages required evaluation.
Is lower serum vitamin D associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus and diabetic kidney disease?
Cross-Sectional (n=76)
No
Is lower serum vitamin D associated with cardiovascular autonomic neuropathy in patients with type 2 diabetes mellitus and diabetic kidney disease?
Vitamin D deficiency is strongly associated with worse cardiovascular autonomic neuropathy parameters in patients with type 2 diabetes and advanced diabetic kidney disease.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for vitamin D assessment in diabetic kidney disease with neuropathy; prospective trials needed before considering supplementation.
Background/objectives: Cardiovascular autonomic neuropathy (CAN) may be associated with other diabetes mellitus-related complications. In addition, lower vitamin D (VD) levels have been associated with diabetic kidney disease (DKD) and diabetic neuropathy. We evaluated the relationship between serum VD and CAN in patients with type 2 Diabetes Mellitus (T2DM) in early and advanced stages of DKD. Methods: Seventy-six T2DM patients, 28 in early DKD stage (urine albumin to creatinine ratio (UACR)): 30 to 299 mg/g - group 1), and 48 in advanced DKD stage (UACR ≥300 mg/g - group 2), participated. Results: In group 1, prevalence of CAN was 46% versus 75% in group 2 (p=0.01). 25(OH)D was lower in group 2 (26.3 ± 9.8 vs 30.0 ± 8.0; p<0.05) and, in this group, those with CAN vs without CAN showed lower 25(OH)D (27.8 ± 8.3 vs 32 ± 6.3; p<0.05). Only in group 2, patients with VD deficiency (<no><20</no> ng/ml) vs normal, showed worse CAN parameters, particularly VLF (65.5 (46-104) vs 309 (106.5-682.5), p<0.01), SDNN (10.5 (8-17.5) vs 28.5 (13-48), p<0.05) and Valsalva Maneuver (1.12 ± 0.04 vs 1.30 ± 0.21, p<0.05). We have found a correlation between VD concentration and CAN prevalence (r = -0.3, p<0.05). Logistic regression showed that VD concentration <no><20</no> ng/ml increased 24 times the chance of abnormal VLF (R²: 0.38; OR: 24.1; 95% (CI: 2.6-222); p<0.01). Conclusions: To our knowledge, this is the first study to demonstrate an association between lower VD and CAN in T2DM and advanced DKD.
No takes yet. Share an insight, caveat, or question.
Felício et al. (2026) conducted a cross-sectional in Type 2 Diabetes Mellitus with Diabetic Kidney Disease (n=76). Vitamin D deficiency (<20 ng/mL) vs. Normal Vitamin D (≥20 ng/mL) was evaluated on Abnormal Very Low Frequency (VLF) test (OR 24.1, 95% CI 2.6-222, p=<0.01). Vitamin D concentration <20 ng/ml increased the odds of an abnormal very low frequency test by 24 times (OR 24.1) in patients with type 2 diabetes and advanced diabetic kidney disease.
Synapse has enriched 10 related papers. Consider them for comparative context: